Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1172 ARTÍCULOS , VIENDO DEL 931 AL 945

Biomarkers in Alzheimer's disease drug development

Cummings JL.

Alzheimers Dement. 2011 May;7(3):e13-44. doi: 10.1016/j.jalz.2010.06.004. Epub 2011 May 6.

Comparison of analytical platforms for cerebrospinal fluid measures of β-amyloid 1-42, total tau, and p-tau181 for identifying Alzheimer disease amyloid plaque pathology

Fagan AM, Shaw LM, Xiong C, Vanderstichele H, Mintun MA, Trojanowski JQ, Coart E, Morris JC, Holtzman DM.

Arch Neurol. 2011 Sep;68(9):1137-44. doi: 10.1001/archneurol.2011.105. Epub 2011 May 9.

Current strategies in the discovery of small-molecule biomarkers for Alzheimer's disease

Whiley L, Legido-Quigley C.

Bioanalysis. 2011 May;3(10):1121-42. doi: 10.4155/bio.11.62.

Development of Alzheimer-disease neuroimaging-biomarkers using mouse models with amyloid-precursor protein-transgene expression

Teipel SJ, Buchert R, Thome J, Hampel H, Pahnke J.

Prog Neurobiol. 2011 Dec;95(4):547-56. doi: 10.1016/j.pneurobio.2011.05.004. Epub 2011 May 12.

Molecular targets in the rational design of AD specific PET tracers: tau or amyloid aggregates?

Rojo LE, Gaspar PA, Maccioni RB.

Curr Alzheimer Res. 2011 Sep;8(6):652-8. doi: 10.2174/156720511796717203.

The concept of FDG-PET endophenotype in Alzheimer's disease

During EH, Osorio RS, Elahi FM, Mosconi L, de Leon MJ.

Neurol Sci. 2011 Aug;32(4):559-69. doi: 10.1007/s10072-011-0633-1. Epub 2011 Jun 1.

Gene expression profiling of peripheral blood leukocytes identifies and validates ABCB1 as a novel biomarker for Alzheimer's disease

Chen KD, Chang PT, Ping YH, Lee HC, Yeh CW, Wang PN.

Neurobiol Dis. 2011 Sep;43(3):698-705. doi: 10.1016/j.nbd.2011.05.023. Epub 2011 Jun 6.

Treat Alzheimer disease before it is symptomatic

Rosenberg RN.

Arch Neurol. 2011 Oct;68(10):1237-8. doi: 10.1001/archneurol.2011.135. Epub 2011 Jun 13.

Biomarkers and gene mutations as aids for detecting AD early

Grandy JK.

JAAPA. 2011 Jun;24(6):56-7. doi: 10.1097/01720610-201106000-00011.

Is hyperhomocysteinemia an Alzheimer's disease (AD) risk factor, an AD marker, or neither?

Zhuo JM, Wang H, Praticò D.

Trends Pharmacol Sci. 2011 Sep;32(9):562-71. doi: 10.1016/j.tips.2011.05.003. Epub 2011 Jun 20.

Review and meta-analysis of biomarkers and diagnostic imaging in Alzheimer's disease

Bloudek LM, Spackman DE, Blankenburg M, Sullivan SD.

J Alzheimers Dis. 2011;26(4):627-45. doi: 10.3233/JAD-2011-110458.

Amyloid-β protein precursor family members: a review from homology to biological function

Huang HC, Jiang ZF.

J Alzheimers Dis. 2011;26(4):607-26. doi: 10.3233/JAD-2011-110335.

Meta-analysis of plasma amyloid-β levels in Alzheimer's disease

Song F, Poljak A, Valenzuela M, Mayeux R, Smythe GA, Sachdev PS.

J Alzheimers Dis. 2011;26(2):365-75. doi: 10.3233/JAD-2011-101977.

Cerebrospinal fluid biomarkers for Alzheimer's disease: the present and the future

Ghidoni R, Benussi L, Paterlini A, Albertini V, Binetti G, Emanuele E.

Neurodegener Dis. 2011;8(6):413-20. doi: 10.1159/000327756. Epub 2011 Jun 25.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias